Industry veteran brings value-based care expertise and supplier-side insights to new role
SKOKIE, Ill., Feb. 17, 2025 /PRNewswire/ — Synapse Health, a leader in advancing the durable medical equipment (DME) industry toward value-based care, today announced the appointment of Shaw Rietkerk as Chief Operating Officer. In this role, Rietkerk will lead Synapse’s core operations and revenue cycle management, bringing best-in-class service for patients, prescribers and supplier partners.
Before joining Synapse, Rietkerk served as Chief Operating Officer of AdaptHealth where he was instrumental in the company’s rapid growth, optimizing operations and revenue cycle management through technology implementation and process improvement. Prior to Adapt, Rietkerk served as EVP & General Manager at Brightree.
“Shaw is a respected industry veteran who understands the challenges our supplier partners face in a rapidly evolving DME landscape. His unique experience with both Adapt and Brightree gives him rare insight into the complexities suppliers of all sizes face in transitioning to value-based care. With Shaw leading our operations, we will strengthen and expand our collaboration with partners to ensure their success within the Synapse model,” said Cory Roberts, co-founder of Synapse Health.
Rietkerk joins Synapse during a period of significant growth, as the company continues making material investments in technology, AI-driven automation, and key system integrations to streamline workflows for suppliers and prescribers while enhancing its self-service patient experience. During his tenure at Adapt, Rietkerk was a supplier partner in Synapse’s initial risk-based model launch, gaining firsthand insight into how Synapse could strengthen suppliers in the movement towards value-based care.
“Joining Synapse felt like a once-in-a-lifetime opportunity to drive meaningful change in an industry where I have spent much of my career. As a former Synapse supplier, I understand the potential of aligning incentives and reducing administrative burdens for suppliers, patients, and referral sources. I am excited to work with our incredible network of partners—many of whom are longtime colleagues and friends—to drive the industry forward by addressing the financial and operational complexities of change together,” said Rietkerk.
Learn more about Synapse Health’s impact at synapsehealth.com.
About Synapse Health
Synapse Health was founded to accelerate the DME industry’s transition to value-based care. Our model empowers high-quality DME suppliers of all sizes—from the smallest to the largest—to compete in a value-based market while advancing patient-first solutions for long-term success. As both an advocate and partner, Synapse is committed to working collaboratively across the industry, championing the vital role of DME suppliers in this evolving landscape. We welcome collaboration and meaningful dialogue with industry stakeholders who share our commitment to progress. If you’re ready to be part of the solution, we’re here to work with you. Reach out at partnerships@synapsehealth.com.
Media Contact:
Dana Coleman
Lovell Communications
dana@lovell.com
SOURCE Synapse Health
An In-Depth Analysis of Digital Sound Frequency Programs, Binaural Beats Research, and Key Considerations for…
Independent analysis examines Fridays' published TRT program structure, delivery format options, and what clinical research…
The Best SARMS for Strength, Cutting, Muscle Growth, Body Building & Recovery - A Guide…
Ozempic for Weight Loss: Does It Work and Is It Safe? Read PhenQ Details –…
Prescription NAD+ Injection Access, At-Home Administration Models, Compounding Standards, and What Consumers Should Know Before…
Telehealth Provider Offers FDA-Approved and Compounded Weight Loss Medications in All 50 States, Subject to…